Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
NIH Career Transition Award (K22) supports NINDS intramural clinician-scientists transitioning to independent research roles.
Funder: National Institutes of Health
Due Dates: June 12, 2025 (New) | July 12, 2025 (Renewal/Resubmission) | October 12, 2025 (New) | November 12, 2025 (Renewal/Resubmission) | February 12, 2026 (New) | March 12, 2026 (Renewal/Resubmission) | June 12, 2026 (New) | July 12, 2026 (Renewal/Resubmission) | October 12, 2026 (New) | November 12, 2026 (Renewal/Resubmission) | February 12, 2027 (New) | March 12, 2027 (Renewal/Resubmission) | June 12, 2027 (New) | July 12, 2027 (Renewal/Resubmission) | October 12, 2027 (New) | November 12, 2027 (Renewal/Resubmission)
Funding Amounts: Up to $125,000/year salary (extramural phase); $50,000/year research costs (extramural); 5-year total project period (2 years intramural, 3+ years extramural); indirect costs at 8% MTDC.
Summary: Supports NINDS intramural neurologist- and neurosurgeon-scientists transitioning to independent, extramural, research-active faculty positions; clinical trials as lead investigator are not allowed.
Key Information: Only NINDS intramural clinician-scientists within 4 years of residency/fellowship completion are eligible; award is limited to U.S. citizens/permanent residents; clinical trial leadership not permitted.
Description
This opportunity provides a two-phase NIH Career Transition Award (K22) specifically for NINDS intramural neurologist- and neurosurgeon-scientists. The program is designed to facilitate the transition from an NIH intramural appointment to an independent, research-active faculty position at an extramural U.S. institution. The award supports both career development and research activities, with the goal of enabling clinician-scientists to establish independent, externally funded research programs while maintaining clinical engagement. The K22 under this announcement does not allow the applicant to lead an independent clinical trial, but participation in a clinical trial led by a mentor is permitted.
